BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1202613)

  • 1. The early effect of trimipramine (Surmontil) on gastric secretion in man.
    Myren J; Berstad A
    Scand J Gastroenterol; 1975; 10(8):817-9. PubMed ID: 1202613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of trimipramine (Surmontil) on gastric secretion of acid and pepsin in man.
    Roland M; Berstad A; Myren J; Liavåg I
    Scand J Gastroenterol Suppl; 1977; 43():19-25. PubMed ID: 323958
    [No Abstract]   [Full Text] [Related]  

  • 3. Nocturnal gastric secretion following treatment with trimipramine (Surmontil).
    Bohman T; Myren J; Berstad A; Flaten O; Larsen S; Larssen E
    Scand J Gastroenterol Suppl; 1982; 72():139-44. PubMed ID: 6813959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of trimipramine (Surmontil) on gastric secretion and the serum gastrin release in healthy young students.
    Bohmann T; Schrumpf E; Myren J
    Scand J Gastroenterol Suppl; 1977; 43():7-17. PubMed ID: 323962
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of TRIMIPRAMINE (Surmontil) on the stimulated gastric secretion and serum gastrin concentration in healthy students.
    Bohman T; Schrumpf E; Myren J; Foss OP
    Scand J Gastroenterol Suppl; 1978; 48():7-49. PubMed ID: 27861
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of pentagastrin-stimulated secretion of acid and pepsin by trimipramine in man.
    Berstad A; Roland M; Myren J
    Scand J Gastroenterol Suppl; 1976; 42():123-5. PubMed ID: 796964
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum concentration of trimipramine (Surmontil) and gastric secretion of acid and pepsin following peroral administration of the drug in healthy humans.
    Myren J; Schrumpf E; Bohman T; Skaug OE; Larsen S
    Scand J Gastroenterol; 1979; 14(2):237-40. PubMed ID: 373073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of trimipramine, cimetidine and atropine on gastric secretion.
    Bohman T; Myren J; Flaten O; Schrumpf E
    Scand J Gastroenterol Suppl; 1980; 58():53-6. PubMed ID: 6929093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of trimipramine (Surmontil) on gastric secretion and peptic ulcer healing.
    Myren J
    Scand J Gastroenterol Suppl; 1977; 43():1-45. PubMed ID: 266269
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of trimipramine (Surmontil) on the gastric secretion of acid and pepsin in patients with duodenal ulceration.
    Mackay HP; Mitchell KG; Pickard WR; Hearns J; Crean GP
    J Int Med Res; 1984; 12(5):303-6. PubMed ID: 6437892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of trimipramine (Surmontil) on ventricle secretion and healing of peptic ulcer].
    Myren J
    Tidsskr Nor Laegeforen; 1977 Feb; 97(5):259. PubMed ID: 320713
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of trimipramine, cimetidine, and atropine on gastric secretion.
    Bohman T; Myren J; Flaten O; Schrumpf E
    Scand J Gastroenterol; 1980; 15(2):177-82. PubMed ID: 7384741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimipramine and duodenal ulcer.
    Valnes K; Skaug OE; Larsen S; Myren J
    Scand J Gastroenterol Suppl; 1980; 58():71-8. PubMed ID: 6929097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a pepsin-inhibitory pentapeptide upon the peptic activity and acidity of gastric secretion.
    Svendsen LB; Guldager N; Christensen L; Christiansen PM
    Scand J Gastroenterol; 1976; 11(5):459-64. PubMed ID: 785587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine and trimipramine on gastric acid secretion in cases of acid peptic disease.
    Mangal BD; Srivastava SK; Srivastava DK; Seth ON
    J Assoc Physicians India; 1986 Jun; 34(6):421-2. PubMed ID: 3771481
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of trimipramine in the management of peptic ulcer.
    Tripathi BM; Misra NP; Rao S; Saifi AQ; Trivedi HH; Singh R; Nigam T
    J Assoc Physicians India; 1985 Feb; 33(2):141-3. PubMed ID: 3997753
    [No Abstract]   [Full Text] [Related]  

  • 17. Dosage of trimipramine.
    Myren J
    Scand J Gastroenterol Suppl; 1980; 58():59-64. PubMed ID: 6929095
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of a pepsin-inhibiting pentapeptide on the secretion of pepsin and hydrochloric acid in the stomach].
    Svendsen LB; Guldager N; Christiansen PM
    Ugeskr Laeger; 1975 Sep; 137(39):2267-9. PubMed ID: 1101497
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastric secretory inhibition by two 16-methylated analogs of prostaglandin E2 given intragastrically to patients with duodenal ulcer disease.
    Nylander B; Andersson S
    Scand J Gastroenterol; 1975; 10(2):217-20. PubMed ID: 1091967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and disturbed motility pattern in the duodenum of man. The effect of l-hyoscyamine, trimipramine and ranitidine on the maximal pressure waves.
    Myren J; Bohman T; Osnes M; Larssen S
    Scand J Gastroenterol Suppl; 1981; 67():1-3. PubMed ID: 6113683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.